Alternative Funding Programs (AFPs) Are Getting the Headlines. But Your PAP Has a Bigger Problem.
April 13, 2026
Stephen Hom
Co-founder & COO
Stephen serves as Chief Operating Officer of RIS Rx, which he co-founded in 2020. Stephen manages all aspects of operations in RIS Rx's patient affordability and gross-to-net (GTN) revenue protection solutions for pharma manufacturers, routinely combining his deep knowledge as a frontline pharmacist with scalable tech-enabled workflows. He earned his PharmD from Loma Linda University.
Insights
Learn why the world's top pharmaceutical companies trust RIS Rx to protect their patients and improve GTN.
RIS Rx offers real-time GTN Revenue Protection to the world's leading pharmaceutical manufacturers, ensuring that every dollar allocated for affordability reaches the right patient at the right time.